Vaccine Therapy and Sargramostim After Rituximab in Treating Patients With Refractory or Progressive Non-Hodgkin's Lymphoma

This study is ongoing, but not recruiting participants.

Study NCT00071955 Information provided by National Cancer Institute (NCI)

First Received: November 4, 2003 Last Updated: April 18, 2009 History of Changes

No Study Results Posted for this Study

Study Status:	This study is ongoing, but not recruiting participants.
Estimated Study Completion Date:	No date given
Estimated Primary Completion Date:	No date given